On September 16, 2021, Chile's Ministry of Health announced major modifications to the country's “Protect Borders” plan, which will now allow for vaccinated non-resident visitors to enter Chile with a “Mobility Pass” (Pase de Movibilidad).  As of September 16, 2021, potential visitors to Chile can apply for a Mobility Pass with proof of vaccination* through the Chilean government's website and receive a pass in approximately a month.  Visitors with a Mobility Pass will be able to enter Chile starting on October 1, 2021.

Restrictions remain the same for those without a Mobility Pass, meaning that the temporary border closure of Chile continues, with only residents and Chilean foreigners granted entry unless a Mobility Pass or a Salvoconducto is obtained.

Even for those with a Mobility Pass, some travel limitations and Covid-19 testing requirements still apply: Mobility Pass tourists may only enter or exit through three airports (Iquique, Antofagasta, and Santiago), must still show proof of a negative PCR test prior to entry, and must have another PCR test at the airport in Chile. Those without a Mobility Pass and only a Salvoconducto can only enter through the Santiago airport.

Mandatory quarantine is still in place for all entering Chile (5 days for those with a Mobility Pass, 7 days for those without a Mobility Pass), though quarantine in a transit hotel is no longer required.

Exit restrictions still apply to Chilean nationals and foreign residents who do not have a valid Mobility Pass. They must request extraordinary authorization for urgent and qualified travel abroad for humanitarian reasons; travel essential to the applicant's health; for essential purposes “for the proper progress of the country”; and to reside abroad.

Exemptions to Chile's continued border closure include cargo transport, through-country transit, children or spouses of Chilean nationals or residents, those entering “for business management purposes . . . for the usefulness of the country” and those entering for humanitarian and diplomatic purposes.

* A Mobility Pass may be granted upon providing proof of being inoculated with any of these vaccines: Moderna, Pfizer/BioNTech, Janssen (Johnson&Johnson), Oxford/AstraZeneca, Sinopharm, Sinovac, CanSino y Generium (Sputnik-V) and a minimum of 14 days have passed from either the second dose (for two-dose vaccines) or inoculation (for one-dose vaccines).

Visit us at mayerbrown.com

Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.

© Copyright 2020. The Mayer Brown Practices. All rights reserved.

This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.